Intent to Sole Source - Flow Cytometry Instrumentation and reagents
Closed Special Notice Posted
- Solicitation number
- W81K00-25-Q-A172
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Jbsa Ft Sam Houston, Texas 78234, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command has issued a Special Notice announcing its intent to sole source flow cytometry instrumentation and reagents for the Department of Pathology & Area Laboratory Services (DPALS) Core Laboratory Department at Brooke Army Medical Center (BAMC) located at Fort Sam Houston, Texas. This procurement falls under the In-Vitro Diagnostic Substance Manufacturing NAICS category and involves establishing a comprehensive testing capability for the military medical facility. The notice indicates no set-aside provisions will be applied to this acquisition. The posting date is August 1, 2025, with responses due by April 15, 2025. The opportunity represents a specialized medical equipment and reagent procurement for military healthcare operations.
The primary objective of this procurement is to establish a cost-per-test agreement that encompasses FDA approved reagents, instrumentation, equipment, consumables, controls, and necessary maintenance services for conducting specific types of medical testing. The testing capabilities required include CDC Basic panel testing, Leukemia/Lymphoma analysis, and Stem Cell/CD34 testing, indicating a focus on hematological and oncological diagnostic services. Contractors interested in this opportunity must be able to provide a comprehensive solution that integrates all required components under a single cost-per-test pricing structure. The sole source nature of this notice suggests the government has identified a specific vendor or solution that meets their technical requirements. Given the specialized nature of flow cytometry equipment and the military medical setting, contractors must demonstrate capability to support complex diagnostic instrumentation and maintain compliance with FDA regulations for medical devices and reagents.
Notice text
The Government’s requirement is to establish a cost-per-test (CPT) agreement to include FDA approved reagents, instrument/equipment, consumables, controls, and any necessary services (e.g., maintenance of furnished equipment) to conduct testing to include CDC Basic panel, Leukemia/Lymphoma, and Stem Cell/CD34 for the Department of Pathology & Area Laboratory Services (DPALS) Core Laboratory Department at Brooke Army Medical Center (BAMC), Fort Sam Houston, TX
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity